MabDesign, the French biotherapy industry association, aims to structure the biopharmaceutical industry in France from its R&D phases to biomanufacturing and marketing. Its objective is also to promote the creation of innovative start-ups resulting from academic research, to increase the visibility of the biopharmaceutical industry, to promote exchanges, to support the development and competitiveness of companies, and to stimulate innovation.
To achieve this objective, MabDesign is setting up a coherent set of actions promoting exchanges, collaborations and the development of skills of the sector's players, as well as supporting companies through tailored studies (intellectual property, innovation financing, market research, marketing & innovation management, business development and monitoring). Operational since September 2015, MabDesign currently has more than 210 member companies, including pharmaceutical and biotech companies, service providers, training organizations, high-tech equipment suppliers and specialized consultants.
One Nucleus is a not-for-profit Life Sciences membership organisation centred on the Greater London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences, we support those institutions, companies and individuals undertaking activity in or with the above region. Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance and help them achieve, or better still exceed, the goals they have set for themselves.
